Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Trinity Meds vs Vea Health

Trinity Meds
Graded #302

Higher grade

vs+6.200000000000003
Vea Health
Graded #451

Lower grade

The verdict

Trinity Meds takes it — 61.2/100 to 55/100.

Trinity Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Trinity Meds is a telehealth weight-loss program aimed at military women, spouses and veterans, offering compounded GLP-1 medication on an all-inclusive flat monthly rate: semaglutide at $149/month and…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueTrinity Meds +19
64
45
Dose & formulationTrinity Meds +13
64
51
Clinical oversightTrinity Meds +8
74
66
Labs & monitoringEven
52
52
FulfillmentEven
68
68
Contract termsVea Health +35
20
55
Trinity Meds · left barVea Health · right bar

The numbers

MetricTrinity MedsVea Health
WeighScore61.2/10055/100
GradeCC
Scorecard rank#302#451
Semaglutide$149/mo (compounded)Not disclosed
Tirzepatide$199/mo (compounded)Not disclosed
CoverageCoverage not publishedAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyYes
Trinity Meds

Graded #302 · C

Strengths

  • All-inclusive flat pricing — $149/month semaglutide, same price at every dose, no hidden fees
  • Multi-month plans cut the cost further (semaglutide to $129/month, tirzepatide to $149/month)
  • No insurance required, FSA eligible, with free shipping to your door
  • Named operating entity (Trinity Meds Inc) and US-licensed clinicians via CareValidate Health

Where it loses points

  • Doesn't publish the states it serves — you only learn eligibility after starting the assessment
  • Pharmacy partners are described as 'multiple USA certified pharmacies' but none are named
  • No terms-of-service page is posted (only a privacy policy)
  • Compounded semaglutide and tirzepatide only — no brand-name or oral options
  • Military framing is marketing; the program and pricing are open to anyone who qualifies
Vea Health

Graded #451 · C

Strengths

  • Publishes the FDA compounded-medication disclaimer
  • Oral and injection protocols for both semaglutide and tirzepatide
  • Claims 50-state coverage via a clinician network
  • Clearly differentiated positioning (longevity, men's health, performance)

Where it loses points

  • Pricing not shown until after sign-up
  • Pharmacy partner not named (only 'U.S.-based pharmacy')
  • LegitScript certification status not visible
  • No named medical director
  • 503A vs 503B designation not specified

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard